In this retrospective review of treatment outcome in elderly patients with advanced-stage lung cancer (EGFR mutation testing was not available in our hospital service within the review period), PS was found to be the only significant determining factor for survival outcome in elderly subjects with advanced stage NSCLC. Here, EGFR is linked to lung cancer.